Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment.
about
Identification of a novel intracellular interaction domain essential for Bves functionVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmCollaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targetingTargeted delivery of therapeutics to endothelium.Equine CTNNB1 and PECAM1 nucleotide structure and expression analyses in an experimental model of normal and pathological wound repair.Spatial distribution of cell adhesion molecules on the peritoneal surface in the cecal perforation-induced peritonitis.Imaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopyIn vitro and In vivo imaging of antivasculogenesis induced by Noggin protein expression in human venous endothelial cellsGI24 enhances tumor invasiveness by regulating cell surface membrane-type 1 matrix metalloproteinase.Platelet Endothelial Cell Adhesion Molecule-1 Gene Polymorphisms are Associated with Coronary Artery Lesions in the Chronic Stage of Kawasaki Disease.PECAM-1: conflicts of interest in inflammation.Differences in platelet endothelial cell adhesion molecule-1 expression between peripheral circulation and pancreatic microcirculation in cerulein-induced acute edematous pancreatitis.Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.Targeting antioxidant and antithrombotic biotherapeutics to endothelium.Isolation of Foreign Material-Free Endothelial Progenitor Cells Using CD31 Aptamer and Therapeutic Application for Ischemic Injury.Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells.Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigrationCD38 autoimmunity: recent advances and relevance to human diabetes.PECAM-1 (CD31) regulates a hydrogen peroxide-activated nonselective cation channel in endothelial cells.Integrin activation by regulated dimerization and oligomerization of platelet endothelial cell adhesion molecule (PECAM)-1 from within the cell.PECAM-1 (CD31) homophilic interaction up-regulates alpha6beta1 on transmigrated neutrophils in vivo and plays a functional role in the ability of alpha6 integrins to mediate leukocyte migration through the perivascular basement membrane.Platelet endothelial cell adhesion molecule-1 and mechanotransduction in vascular endothelial cells.PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesisRhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1.Molecular events during leukocyte diapedesis.Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans.Angiogenesis in platelet endothelial cell adhesion molecule-1-null miceVascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanisms.PECAM-1 and caveolae form the mechanosensing complex necessary for NOX2 activation and angiogenic signaling with stopped flow in pulmonary endothelium.Optical imaging of the adoptive transfer of human endothelial cells in mice using anti-human CD31 monoclonal antibody.Endothelial nanomedicine for the treatment of pulmonary disease.Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1.Isolation, propagation, characterization, cryopreservation, and application of novel cardiovascular endothelial cell line from Channa striatus (Bloch, 1793).Influence of PECAM-1 ligand interactions on PECAM-1-dependent cell motility and filopodia extensionc7E3 Fab inhibits human tumor angiogenesis in a SCID mouse human skin xenograft model.Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration.Expression pattern of alternatively spliced PECAM-1 isoforms in hematopoietic cells and platelets.Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1.Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils.
P2860
Q21144305-673AE1F1-1EB9-401C-BCC8-DB5AA883CBAFQ27026630-5FD2D24A-D51E-47AA-B2CF-DF096D8F40DAQ28482282-E1A816DE-0400-458D-9A34-7706C3B064A8Q30475849-37C30C34-95AC-4D79-9089-3A19A2B6015BQ30840661-88401E86-8F26-4F80-A0D7-223AE459E6BBQ31014947-DFC45F6F-3AC7-4C75-9249-A0BEF5BD854FQ33571085-66A42D55-984A-4305-9652-A839806D0445Q33613227-50727996-423A-44D0-8BBC-F02770660BAAQ33643506-0A981060-EE01-410E-8F9D-B0AC4DCEA417Q33729848-44ADB347-480C-464B-B444-61BE80E941CCQ34049296-50E48BF2-C78B-436A-AFA5-49FF1A09CCAAQ34605375-EFEA69BC-D834-4322-8221-4A388F70F421Q34787599-507E701F-8EC2-4C42-8291-EE108DC74902Q34935960-FD43DF68-66B0-4FE9-8A86-E9DE15C407A7Q35684128-7733F183-20CB-4A89-83D1-9FB6046F715BQ35749239-AB1002E9-E795-47AE-BC27-91D024B6FBF2Q35788765-88460DA7-DBE6-4EB5-8511-ECD024DE85D8Q35928098-E1C417F4-9A57-4197-BE20-1D67BA539F89Q36324100-BA9B4A2F-1FFB-42FD-8D80-A23849B64EF2Q36370009-5528AE10-509F-4CD1-8CA3-2DF4C76E4C75Q36371472-93D05694-19AE-4770-ABB6-A2503AD3B643Q36440501-2A68043D-FAFC-41C6-B778-FB70EF666461Q36473318-2B74181B-EBE3-4694-A967-9D9365FA8875Q36491844-64A24726-9086-4C6E-9F55-2A178E0A1D08Q36590776-61743F04-17E5-4BD7-84C7-507E55531FD3Q36601477-81350FD4-2430-4EA7-899B-641DAB37D185Q37134054-A19C5558-1AD7-4CCE-9FC4-F3DE69A14137Q37278535-0B0EA886-3C5E-4A3B-97CF-60FC9DFAEE6AQ37328421-75FF65D0-7B57-4EA9-A890-81910DD38440Q37440498-C682C1DD-2740-45F4-AF02-15484DE582ADQ37481511-DA0D2E12-36BC-436E-AE32-760154059714Q38267984-0ECBA539-ED72-4739-9D6D-FCE3F745BEA1Q38875899-561A34D1-C0E6-489D-9E11-4083EB31DE8BQ38959167-6E88D4A9-D298-4A89-8BAB-6ACCE254F3C7Q39147388-5B663FC2-73DE-43BD-8BD1-C2350E31B14BQ40207855-52BACD9E-D6C0-4BC2-91DA-EE92E21FD58BQ40544658-905AB05D-D4F1-43DF-BC91-39D1BCB316B3Q40694542-66275275-9583-4B30-A114-5F8CABF5E9BAQ40923925-DF42AE42-EF9D-451D-9F74-EE2EBF6AB026Q42099003-454A244F-2694-4DD2-B66A-F9AD33A642EE
P2860
Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Antibodies against the first I ...... n vivo neutrophil recruitment.
@en
type
label
Antibodies against the first I ...... n vivo neutrophil recruitment.
@en
prefLabel
Antibodies against the first I ...... n vivo neutrophil recruitment.
@en
P2093
P1476
Antibodies against the first I ...... n vivo neutrophil recruitment.
@en
P2093
Albelda SM
Christofidou-Solomidou M
DeLisser HM
Gurubhagavatula I
Heavner GA
O'Brien CD
P304
P356
10.4049/JIMMUNOL.164.1.452
P407
P577
2000-01-01T00:00:00Z